OMP and Paediatric Regulations General Consultation

On 7 May, the European Commission opened its public consultation on the revision of EU rules on medicines for children and rare diseases. The consultation, aimed at stakeholders and members of the general public, including patients and doctors, will explore several options to address the shortcomings identified in the evaluation of the Regulations on medicines for children and rare diseases, in view of a revision of the existing legislation.

EUCOPE will take part into the consultation. If you want to know more about our efforts on rare diseases, please contact Vittoria Carraro, and have a look at our Rare Diseases Hub.